Bromelain‐based enzymatic burn debridement: A systematic review of clinical studies on patient safety, efficacy and long‐term outcomes

In 2012 the European Medicines Agency approved a pineapple stem‐derived Bromelain‐based debridement concentrate of proteolytic enzymes (NexoBrid®, MediWound Ltd, Yavne, Israel) for adult deep burns. Over 10 000 patients have been successfully treated with NexoBrid® globally, including in the US. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoham, Yaron, Gasteratos, Konstantinos, Singer, Adam J., Krieger, Yuval, Silberstein, Eldad, Goverman, Jeremy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681521/
https://www.ncbi.nlm.nih.gov/pubmed/37455553
http://dx.doi.org/10.1111/iwj.14308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681521/
https://www.ncbi.nlm.nih.gov/pubmed/37455553
http://dx.doi.org/10.1111/iwj.14308

Ejemplares similares